Lupravir Capsule 200 mg
Lupravir Capsule 200 mg Uses, Dosage, Side Effects, Food Interaction and all others data.
| Trade Name | Lupravir Capsule 200 mg |
| Generic | Molnupiravir |
| Weight | 200 mg |
| Type | Capsule |
| Therapeutic Class | |
| Manufacturer | Renata Limited |
| Available Country | Bangladesh |
| Last Updated: | October 19, 2023 at 6:27 am |
Uses
Lupravir Capsule 200 mg is an antiviral medicine used to treat mild to moderate C0VID-19 (caused by SARS-CoV-2) in adults who are at risk for developing severe illness. Lupravir Capsule 200 mg may help people with C0VID-19 stay out of the hospital and feel better. Emergency use authorized oral therapeutic for the treatment ... Read moreDosage
Lupravir Capsule 200 mg dosage
The recommended dose of Lupravir Capsule 200 mg is four 200 mg capsules (4+0+4), every 12 hours for 5 days. Do not give this medicine to children and adolescents aged less than 18 years. The use of Lupravir Capsule 200 mg in persons aged less than 18 years has not yet been studied.Side Effects
Common side effects include diarrhoea, nausea, feeling dizzy, headache.Precaution
There are limited clinical data available for Lupravir Capsule 200 mg. Serious and unexpected adverse events may occur that have not been previously reported with Lupravir Capsule 200 mg use.Interaction
No drug interactions have been identified based on the limited available data. No clinical interaction studies have been performed with Lupravir Capsule 200 mg. Lupravir Capsule 200 mg is hydrolysed to n-hydroxycytidine (NHC) prior to reaching systemic circulation. Uptake of NHC and metabolism to NHC-TP are mediated by the same pathways involved in endogenous pyrimidine metabolism. NHC is not a substrate of major drug metabolising enzymes or transporters. Based on in vitro studies, neither molnupiravir nor NHC are inhibitors or inducers of major drug metabolising enzymes or inhibitors of major drug transporters. Therefore, the potential for molnupiravir or NHC to interact with concomitant medications is considered unlikely.Pregnancy & Breastfeeding use
Animal studies with molnupiravir have shown harmful effects to the unborn animal. Lupravir Capsule 200 mg is not recommended in pregnancy. Lupravir Capsule 200 mg has not been studied in pregnancy and it is not known if Lupravir Capsule 200 mg will harm your baby while you are pregnant. If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor for advice. If you can become pregnant, you should use effective birth control while you are taking Lupravir Capsule 200 mg and for 4 days after the last dose of Lupravir Capsule 200 mg. If you are breast-feeding or are planning to breastfeed, tell your doctor before taking this medicine. Breast-feeding is not recommended during treatment and for 4 days after the last dose of Lupravir Capsule 200 mg. This is because it is not known if Lupravir Capsule 200 mg gets into breast milk and will be passed to the baby.Contraindication
Lupravir Capsule 200 mg is contraindicated in patients with known hypersensitivity to Lupravir Capsule 200 mg.Storage Condition
Store at or below 25°C temperature. Keep away from light and wet places. Keep out of reach of children.Innovators Monograph
You find simplified version here Lupravir Capsule 200 mg
